Oncology & Cancer

Bevacizumab ovarian cancer trial: Real-world impact?

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...

Oncology & Cancer

Fat-rich fluid found to fuel immune failure in ovarian cancer

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new insights ...

Obstetrics & gynaecology

New tool to fast-track ovarian cancer diagnosis

A woman's chances of surviving ovarian cancer at least five years after diagnosis come down to the toss of a coin: just 49% will reach that milestone, making it one of the most lethal reproductive cancers worldwide.

page 2 from 40